Dengue fever is a mosquito-borne viral infection caused by the dengue virus, belonging to the Flavivirus genus and primarily transmitted by Aedes mosquitoes. It is prevalent in tropical and sub-tropical regions, affecting millions of people globally each year. The World Health Organization (WHO) estimates that about 390 million dengue infections occur annually, with approximately 96 million manifesting clinically. The epidemiology of dengue is influenced by several factors, including climate change, urbanization, and globalization, which facilitate the spread of the vector and the virus. While the typical presentation of dengue includes high-grade fever, headache, myalgia, arthralgia, and rash, the disease can escalate to more severe forms, such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). These severe forms can lead to life-threatening complications, necessitating prompt recognition and intervention. DHF is characterized by plasma leakage, thrombocytopenia, and hemorrhagic manifestations, which can culminate in significant morbidity and mortality. The pathophysiology underlying these severe manifestations is complex and involves the interplay of the virus, host immune response, and genetic predisposition. Additionally, neurological involvement, such as dengue encephalitis, and gastrointestinal (GI) complications, such as upper GI bleeding, are rare but increasingly recognized complications. This case report describes the clinical course of a young adult male who initially presented with typical dengue symptoms but developed severe complications during hospitalization. His clinical course included the development of dengue encephalitis and upper GI bleeding, both of which were primarily driven by plasma leakage and dengue hemorrhagic fever. Through this case, we aim to shed light on the atypical manifestations of dengue fever and the importance of early recognition and management of these complications.
Published in | American Journal of Internal Medicine (Volume 12, Issue 6) |
DOI | 10.11648/j.ajim.20241206.14 |
Page(s) | 125-130 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Dengue, Flavivirus, Aedes, Rash, Plasma Leakage, Dengue Encephalitis, Upper GI Bleeding, Myalgia, Fever, Hem-concentration, Thrombocytopenia
[1] | Baheti, G., Mehta, V., Ramchandani, M., & Ghosh, G. C. Dengue fever with encephalitis: a rare phenomenon. BMJ Case Reports. 2018. |
[2] | Rao, S., Kumar, M., Ghosh, S., & Gadpayle, A. K. A rare case of dengue encephalitis. BMJ Case Reports. 2013. |
[3] | Baldaçara, L., et al. Neuroimaging of dengue encephalitis: MRI findings in a case report. Frontiers in Neurology. 2013. |
[4] | Madi, D., & Acharya, V. Atypical manifestations of dengue fever. Journal of Clinical and Diagnostic Research. 2015 Jun; 9(6): OD09–OD10. |
[5] | Misra, U. K., & Kalita, J. Dengue fever and encephalopathy. Journal of Neurology, Neurosurgery & Psychiatry. 2006 Aug; 77(8): 970–973. |
[6] | Garg, R. K., Malhotra, H. S., & Kumar, N. Encephalopathy in dengue fever: Clinical and neuroimaging manifestations. Journal of Neurological Sciences. 2017 Jan; 373: 1–8. |
[7] | Liou, L. M., et al. Acute encephalopathy in patients with dengue fever. Journal of the Neurological Sciences. 2008 Aug; 272(1-2): 103–105. |
[8] | Thisyakorn, U., & Thisyakorn, C. Neurological manifestations in dengue patients. Pediatric Infectious Disease Journal. 2001 May; 20(5): 458–459. |
[9] | Sumarmo, S., et al. Encephalopathy associated with dengue haemorrhagic fever. Journal of Neurology, Neurosurgery, and Psychiatry. 1983 Aug; 46(8): 779–785. |
[10] | Yung, C. F., et al. Dengue serotype-specific differences in clinical manifestations, laboratory findings, and outcomes. PLoS ONE. 2015 Dec; 10(12): e0123822. |
[11] | Hendarto, S. K., & Hadinegoro, S. Dengue encephalopathy in children. Journal of Pediatric Infectious Diseases. 1992 Jun; 11(6): 1121–1123. |
[12] | Gupta, N., Srivastava, S., Jain, A., & Chaturvedi, U. C. Dengue in India. Indian Journal of Medical Research. 2012 Mar; 136(3): 373–390. |
[13] | Guzman, M. G., & Harris, E. Dengue. The Lancet. 2015 Feb 7; 385(9966): 453–465. |
[14] | Sahu, R., et al. Neurological complications in dengue infection: A study of hospital-based patients. Asian Pacific Journal of Tropical Medicine. 2014 Mar; 7(3): 253–256. |
APA Style
Hafeez, W., Ashraf, M. A., Asif, F., Arbaz, H. M., Umar, M., et al. (2024). The Neurological and Hemorrhagic Faces of Dengue: A Case of Encephalitis with Upper GI Bleed. American Journal of Internal Medicine, 12(6), 125-130. https://doi.org/10.11648/j.ajim.20241206.14
ACS Style
Hafeez, W.; Ashraf, M. A.; Asif, F.; Arbaz, H. M.; Umar, M., et al. The Neurological and Hemorrhagic Faces of Dengue: A Case of Encephalitis with Upper GI Bleed. Am. J. Intern. Med. 2024, 12(6), 125-130. doi: 10.11648/j.ajim.20241206.14
@article{10.11648/j.ajim.20241206.14, author = {Waqar Hafeez and Muhammad Abdullah Ashraf and Fatima Asif and Hafiz Muhammad Arbaz and Muhammad Umar and Muhammad Hassaan}, title = {The Neurological and Hemorrhagic Faces of Dengue: A Case of Encephalitis with Upper GI Bleed }, journal = {American Journal of Internal Medicine}, volume = {12}, number = {6}, pages = {125-130}, doi = {10.11648/j.ajim.20241206.14}, url = {https://doi.org/10.11648/j.ajim.20241206.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20241206.14}, abstract = {Dengue fever is a mosquito-borne viral infection caused by the dengue virus, belonging to the Flavivirus genus and primarily transmitted by Aedes mosquitoes. It is prevalent in tropical and sub-tropical regions, affecting millions of people globally each year. The World Health Organization (WHO) estimates that about 390 million dengue infections occur annually, with approximately 96 million manifesting clinically. The epidemiology of dengue is influenced by several factors, including climate change, urbanization, and globalization, which facilitate the spread of the vector and the virus. While the typical presentation of dengue includes high-grade fever, headache, myalgia, arthralgia, and rash, the disease can escalate to more severe forms, such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). These severe forms can lead to life-threatening complications, necessitating prompt recognition and intervention. DHF is characterized by plasma leakage, thrombocytopenia, and hemorrhagic manifestations, which can culminate in significant morbidity and mortality. The pathophysiology underlying these severe manifestations is complex and involves the interplay of the virus, host immune response, and genetic predisposition. Additionally, neurological involvement, such as dengue encephalitis, and gastrointestinal (GI) complications, such as upper GI bleeding, are rare but increasingly recognized complications. This case report describes the clinical course of a young adult male who initially presented with typical dengue symptoms but developed severe complications during hospitalization. His clinical course included the development of dengue encephalitis and upper GI bleeding, both of which were primarily driven by plasma leakage and dengue hemorrhagic fever. Through this case, we aim to shed light on the atypical manifestations of dengue fever and the importance of early recognition and management of these complications. }, year = {2024} }
TY - JOUR T1 - The Neurological and Hemorrhagic Faces of Dengue: A Case of Encephalitis with Upper GI Bleed AU - Waqar Hafeez AU - Muhammad Abdullah Ashraf AU - Fatima Asif AU - Hafiz Muhammad Arbaz AU - Muhammad Umar AU - Muhammad Hassaan Y1 - 2024/12/27 PY - 2024 N1 - https://doi.org/10.11648/j.ajim.20241206.14 DO - 10.11648/j.ajim.20241206.14 T2 - American Journal of Internal Medicine JF - American Journal of Internal Medicine JO - American Journal of Internal Medicine SP - 125 EP - 130 PB - Science Publishing Group SN - 2330-4324 UR - https://doi.org/10.11648/j.ajim.20241206.14 AB - Dengue fever is a mosquito-borne viral infection caused by the dengue virus, belonging to the Flavivirus genus and primarily transmitted by Aedes mosquitoes. It is prevalent in tropical and sub-tropical regions, affecting millions of people globally each year. The World Health Organization (WHO) estimates that about 390 million dengue infections occur annually, with approximately 96 million manifesting clinically. The epidemiology of dengue is influenced by several factors, including climate change, urbanization, and globalization, which facilitate the spread of the vector and the virus. While the typical presentation of dengue includes high-grade fever, headache, myalgia, arthralgia, and rash, the disease can escalate to more severe forms, such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). These severe forms can lead to life-threatening complications, necessitating prompt recognition and intervention. DHF is characterized by plasma leakage, thrombocytopenia, and hemorrhagic manifestations, which can culminate in significant morbidity and mortality. The pathophysiology underlying these severe manifestations is complex and involves the interplay of the virus, host immune response, and genetic predisposition. Additionally, neurological involvement, such as dengue encephalitis, and gastrointestinal (GI) complications, such as upper GI bleeding, are rare but increasingly recognized complications. This case report describes the clinical course of a young adult male who initially presented with typical dengue symptoms but developed severe complications during hospitalization. His clinical course included the development of dengue encephalitis and upper GI bleeding, both of which were primarily driven by plasma leakage and dengue hemorrhagic fever. Through this case, we aim to shed light on the atypical manifestations of dengue fever and the importance of early recognition and management of these complications. VL - 12 IS - 6 ER -